ESCA

Escalade is a quality small-cap running in place. Revenue has fallen four straight years — $314M (FY2021) → $264M (FY2023) → $240M (FY2025), down another 4.5% last year — in what management itself calls 'highly fragmented and intensely competitive' markets 'experiencing low growth rates.' The bull case isn't growth; it's discipline. Despite the -4.5% top line, FY2025 net income rose 5.5% to $13.7M and diluted EPS grew 6.5% to $0.99, as the company finished 'reducing inventory to more normalized levels across most of its categories' (MD&A), which lifted quality of earnings even as operating income slipped 6.4%.

The balance sheet is the standout and the reason to own it rather than avoid it. Liabilities/equity is just 0.28x, long-term debt fell 38.7% to $11.3M, cash nearly tripled (+183%) to $11.9M, and equity is $173M against a $261M market cap. Operating cash flow of $31.0M against only $2.5M capex funds a well-covered dividend ($8.28M paid, ~3.2% yield) plus $3.1M of buybacks — the FCF yield on this market cap is roughly 11%. This is a self-funding cash machine, not a distressed name.